BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15734860)

  • 1. Pioglitazone induces vascular smooth muscle cell apoptosis through a peroxisome proliferator-activated receptor-gamma, transforming growth factor-beta1, and a Smad2-dependent mechanism.
    Redondo S; Ruiz E; Santos-Gallego CG; Padilla E; Tejerina T
    Diabetes; 2005 Mar; 54(3):811-7. PubMed ID: 15734860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway.
    Ruiz E; Redondo S; Gordillo-Moscoso A; Tejerina T
    J Pharmacol Exp Ther; 2007 May; 321(2):431-8. PubMed ID: 17267584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells.
    Guo B; Koya D; Isono M; Sugimoto T; Kashiwagi A; Haneda M
    Diabetes; 2004 Jan; 53(1):200-8. PubMed ID: 14693716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
    Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
    Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1.
    Redondo S; Hristov M; Gümbel D; Tejerina T; Weber C
    Thromb Haemost; 2007 Jun; 97(6):979-87. PubMed ID: 17549301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.
    Gao DF; Niu XL; Hao GH; Peng N; Wei J; Ning N; Wang NP
    Biochem Pharmacol; 2007 Jan; 73(2):185-97. PubMed ID: 17074304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early stimulation and late inhibition of peroxisome proliferator-activated receptor gamma (PPAR gamma) gene expression by transforming growth factor beta in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads.
    Fu M; Zhang J; Lin Y; Zhu X; Zhao L; Ahmad M; Ehrengruber MU; Chen YE
    Biochem J; 2003 Mar; 370(Pt 3):1019-25. PubMed ID: 12457461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
    Nuwormegbe SA; Sohn JH; Kim SW
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
    Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
    J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferation-activated receptor-γ inhibits transforming growth factor-β1-induced airway smooth muscle cell proliferation by suppressing Smad-miR-21 signaling.
    Liu L; Pan Y; Zhai C; Zhu Y; Ke R; Shi W; Wang J; Yan X; Su X; Song Y; Gao L; Li M
    J Cell Physiol; 2018 Jan; 234(1):669-681. PubMed ID: 30132829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells.
    Okura T; Nakamura M; Takata Y; Watanabe S; Kitami Y; Hiwada K
    Eur J Pharmacol; 2000 Nov; 407(3):227-35. PubMed ID: 11068018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
    Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
    BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.
    Zafiriou S; Stanners SR; Saad S; Polhill TS; Poronnik P; Pollock CA
    J Am Soc Nephrol; 2005 Mar; 16(3):638-45. PubMed ID: 15689403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition-like phenotypic changes of retinal pigment epithelium induced by TGF-β are prevented by PPAR-γ agonists.
    Hatanaka H; Koizumi N; Okumura N; Kay EP; Mizuhara E; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6955-63. PubMed ID: 22956604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction.
    Hou J; Wang L; Hou J; Guo T; Xing Y; Zheng S; Zhou C; Huang H; Long H; Zhong T; Wu Q; Wang J; Wang T
    Stem Cell Rev Rep; 2015 Dec; 11(6):885-99. PubMed ID: 26275398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, induces dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels.
    Omae T; Nagaoka T; Tanano I; Yoshida A
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6749-56. PubMed ID: 21757589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
    Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
    J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
    Osman I; Segar L
    Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of peroxisome proliferator-activated receptor-γ activation on apoptosis in rats with acute pancreatitis.
    Xu P; Lou XL; Chen C; Yang ZW
    Dig Dis Sci; 2013 Dec; 58(12):3516-23. PubMed ID: 24185678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.